SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 21 filers reported holding SAVARA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $393 | -49.2% | 103,900 | -57.1% | 0.00% | 0.0% |
| Q2 2023 | $774 | +294.9% | 242,300 | +140.6% | 0.00% | – |
| Q1 2023 | $196 | +79.8% | 100,700 | +43.7% | 0.00% | – |
| Q4 2022 | $109 | -99.9% | 70,100 | +0.1% | 0.00% | – |
| Q3 2022 | $109,000 | +28.2% | 70,000 | +25.0% | 0.00% | – |
| Q2 2022 | $85,000 | +286.4% | 56,000 | +235.3% | 0.00% | – |
| Q1 2022 | $22,000 | -94.8% | 16,700 | -95.2% | 0.00% | -100.0% |
| Q4 2021 | $427,000 | -0.5% | 344,492 | +10.7% | 0.00% | 0.0% |
| Q3 2021 | $429,000 | +44.0% | 311,200 | +77.5% | 0.00% | – |
| Q2 2021 | $298,000 | +120.7% | 175,349 | +171.0% | 0.00% | – |
| Q1 2021 | $135,000 | -70.7% | 64,700 | -83.8% | 0.00% | – |
| Q4 2020 | $460,000 | +8.2% | 399,900 | +2.6% | 0.00% | – |
| Q3 2020 | $425,000 | -2.3% | 389,700 | +301.0% | 0.00% | – |
| Q4 2019 | $435,000 | -6.7% | 97,182 | +53.8% | 0.00% | – |
| Q1 2019 | $466,000 | -77.4% | 63,183 | -71.8% | 0.00% | -100.0% |
| Q2 2018 | $2,058,000 | 0.0% | 223,683 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $2,058,000 | +270.1% | 223,683 | +496.8% | 0.00% | +100.0% |
| Q4 2017 | $556,000 | +473.2% | 37,483 | +260.2% | 0.00% | – |
| Q3 2017 | $97,000 | -23.0% | 10,407 | -51.6% | 0.00% | – |
| Q2 2017 | $126,000 | – | 21,507 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 3,313,602 | $12,525,416 | 47.59% |
| NEA Management Company, LLC | 24,471,264 | $92,501,378 | 7.14% |
| Bain Capital Life Sciences Investors, LLC | 14,232,751 | $53,799,799 | 6.02% |
| TCG Crossover Management, LLC | 10,000,000 | $37,800,000 | 5.57% |
| VR Adviser, LLC | 7,184,865 | $27,158,790 | 2.86% |
| Affinity Asset Advisors, LLC | 1,150,000 | $4,347,000 | 1.22% |
| Sio Capital Management, LLC | 896,250 | $3,387,825 | 1.05% |
| Frazier Life Sciences Management, L.P. | 4,000,000 | $15,120,000 | 1.00% |
| Vivo Capital, LLC | 1,913,349 | $7,232,459 | 0.79% |
| Nantahala Capital Management | 1,039,364 | $3,928,796 | 0.34% |